News

Introducing the BIA Skin Barrier Support for Kids Under 12

Introducing the BIA Skin Barrier Support for Kids Under 12

Introducing BIA Skin Barrier Support Supplements

Codex Labs, a pioneering skintech company based in Silicon Valley, has unveiled its latest product, the BIA Skin Barrier Support supplements. These supplements are specially formulated for children aged 12 and under. The new offerings come in two forms to cater to different age groups: an unflavored powder for infants and toddlers from 3 months to 3 years, and a delicious mixed-berry-flavored gummy for kids aged 4 to 12.

Key Ingredients Beneficial for Skin Health

Both the infant/toddler powder and the kids' gummies are enriched with L-Histidine, a vital amino acid that plays a significant role in the synthesis of filaggrin, an essential structural protein that supports the skin barrier. This protein is crucial for maintaining skin hydration and integrity, as it directly influences the Natural Moisturization Factor (NMF) that the skin relies on to attract and retain moisture. Beyond L-Histidine, the supplements include a blend of important vitamins and minerals designed to enhance the skin barrier, helping to reduce sensitivity and prevent dehydration.

Safe Alternatives for Managing Eczema

Dr. Neil K. Gibbs, the founder of Curapel, emphasized the importance of providing safe skincare solutions for eczema-prone children. He noted that long-term use of topical corticosteroids may not be advisable for young children. Instead, the innovative BIA supplement products containing L-Histidine offer a safe and effective alternative, addressing the skincare needs of young individuals. Dr. Peter Lio, a medical advisor at Codex Labs, further highlighted the benefits of integrating these supplements with the BIA Eczema Relief Lotion and BIA Unscented Soap. Together, they create a comprehensive, multifaceted approach to managing atopic dermatitis in younger patients.

Clinical Research Backed by Results

In a randomized, placebo-controlled, double-blind clinical pilot study involving children aged 1 to 7 years with mild to moderate eczema, impressive results were reported. The severity of eczema, measured by the EASI score, improved by 49% after 12 weeks of using the BIA supplements. This degree of improvement matches the outcomes typically associated with the use of mid-potency topical corticosteroids, showcasing the effectiveness of these supplements in addressing eczema symptoms.

Commitment to Quality and Safety

All products by Codex Labs are manufactured in cutting-edge cGMP facilities, ensuring each batch undergoes rigorous third-party testing to guarantee their quality. This commitment to safety and efficacy is part of Codex Labs' overarching mission.

About Codex Labs

Codex Labs is dedicated to creating skin-gut-brain-biome solutions that harness potent, plant-based biotech actives. Under the leadership of Dr. Barb Paldus, the company focuses on addressing various skin conditions, including eczema, acne, and rosacea. They aim to enhance the health of skin by restoring barriers and microbiomes while managing systemic inflammation effectively. Their products have received praise from integrative dermatologists and naturopathic professionals for being the next generation of effective, cruelty-free topicals and supplements.

About Curapel

Curapel, established by Dr. Neil K. Gibbs and originally developed at the University of Manchester Dermatology Centre, specializes in researching and formulating unique dermatological products. Their line of nutraceutical skincare focuses on natural ingredients to treat common skin conditions. Curapel's technology has been clinically validated, strengthening their product's claims against conditions such as eczema and psoriasis while paving the way for future developments in skin health.

Frequently Asked Questions

What are the main benefits of the BIA Skin Barrier Support supplements?

The BIA Skin Barrier Support supplements are designed to strengthen the skin barrier, reduce sensitivity, and help retain moisture for children prone to eczema.

Who can take the BIA Skin Barrier Support supplements?

These supplements are tailored for children under the age of 12, with specific formulations for infants, toddlers, and kids.

How do these supplements compare to topical corticosteroids?

The BIA supplements offer a safer alternative to corticosteroids, providing effective management of eczema symptoms without the associated risks of long-term topical steroid use.

What is L-Histidine, and why is it important?

L-Histidine is an amino acid that supports the production of filaggrin, critical for maintaining the skin's barrier function and hydration.

Are the BIA supplements clinically tested?

Yes, the BIA supplements have undergone clinical trials, demonstrating a significant improvement in eczema severity in young children.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 6

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 9

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 7

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 6

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 6

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights into Precigen's Upcoming Earnings Event

Updated Category News Views 127

Overview of Precigen's Earnings Expectations Precigen (NASDAQ:PGEN) is gearing up for the release of its quarterly earnings report, creating a buzz among investors who are eagerly anticipating the company's performance. This quarterly update will provide crucial insights needed to navigate investment decisions in the coming weeks. Anticipated Earnings Market analysts are...

Continue Reading
Upcoming Housing Initiative Announcement: Join the Conversation

Updated Category News Views 136

Join Us for a Significant Housing Initiative Announcement In a proactive step towards addressing housing challenges, a notable announcement is set to occur soon. This event will feature key figures in government and infrastructure, spearheading discussions that are crucial for our communities. Engaging directly with the speakers will offer insight into the new initiatives...

Continue Reading
Viking Therapeutics Launches Phase 3 Study for VK2735

Updated Category News Views 446

Viking Therapeutics Unveils Phase 3 Clinical Program for VK2735 Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company invested in developing novel therapies, recently announced an exciting milestone: the initiation of its Phase 3 clinical program for VK2735, a dual agonist targeting the GLP-1 and GIP receptors. This innovative therapy is under evaluation...

Continue Reading
Chlorine Dioxide Market Growth Driven by Innovation and Demand

Updated Category News Views 139

Chlorine Dioxide Market Overview The Chlorine Dioxide Market is currently experiencing significant growth, primarily driven by increasing demands across key sectors such as water treatment, healthcare, food processing, and the pulp & paper industries. The growing focus on safe disinfection solutions and sustainability initiatives is leading to increased adoption of...

Continue Reading
MarketAxess Holdings' Upcoming Earnings Report Analysis

Updated Category News Views 129

Overview of MarketAxess Holdings' Earnings Report MarketAxess Holdings (NASDAQ: MKTX) is poised to release its latest quarterly earnings report soon. Investors are keen to understand the implications of this announcement, which promises insights into the company's performance and future guidance. Analyst Expectations Market analysts anticipate that the earnings per share...

Continue Reading